Torrent Pharmaceuticals puts faith in local market, to focus on new drug launches - (The Economic Times via NewsPoints Desk)

  • Torrent Pharmaceuticals is optimistic that the future of Indian drugmakers is in the domestic market, as it looks at new launches in the lucrative chronic therapy areas, reported The Economic Times.

  • "Our key geographies of India, Brazil and Germany are where we expect future growth avenues to come from," said Aman Mehta, chief marketing officer of Torrent, adding "we are seeing from other companies, too, a lot more focus back on the Indian market."

  • For now, he said Torrent's focus will be on launching new products in categories such as cardiology and diabetes.

  • According to the news source, Torrent is betting on its new launches like the cardiac drug ticagrelor and anti-diabetic treatments vildagliptin and remogliflozin for its future quarter growth.

To read more NewsPoints articles, click here.